Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 4
283
Views
10
CrossRef citations to date
0
Altmetric
Research Articles

A new anti-inflammatory lignan from Lonicerae Japonicae flos

ORCID Icon, ORCID Icon, &
Pages 587-592 | Received 26 Jan 2019, Accepted 22 Feb 2019, Published online: 14 Mar 2019
 

Abstract

One new lignan, loniceralanside A (1), together with three known compounds (2–4), were purified from Lonicerae Japonicae Flos. Their structures were determined by HR-ESI-MS, 1 D and 2 D NMR data. Compounds 2–4 were separated from the plant for the first time. The biological test showed that compound 1 had significant anti-inflammatory activity with inhibiting the release of β-glucuronidase induced by platelet-activating factor (PAF) in rat polymorphonuclear leukocytes (PMNs) (IC50 = 3.05 µM).

Graphical Abstract

Acknowledgements

We are grateful to Shandong University of Traditional Chinese Medicine for the donation of plant materials.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the Standardization Project Fund of Administration of Traditional Chinese Medicine [grant number: ZYBZH-Y-SD-32], Postdoctoral Science Foundation of China [grant number: 2017M622268], Specialized Fund for Dependent Innovation of Shandong Province [grant number: 2016GSF202009].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.